# EDGAR Filing Document

**Accession Number:** 0001666700
**File Stem:** 0001666700-26-000034
**Filing Date:** 2026-5
**Character Count:** 17839
**Document Hash:** d8d9e63274ba226fb9fe3a809d6d8ad1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001666700-26-000034.hdr.sgml**: 20260526

**ACCESSION NUMBER**: 0001666700-26-000034

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20260521

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260526

**DATE AS OF CHANGE**: 20260526

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** DuPont de Nemours, Inc.
- **CENTRAL INDEX KEY:** 0001666700
- **STANDARD INDUSTRIAL CLASSIFICATION:** PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 811224539
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38196
- **FILM NUMBER:** 261020135

**BUSINESS ADDRESS:**
- **STREET 1:** 974 CENTRE ROAD
- **STREET 2:** BUILDING 730
- **CITY:** WILMINGTON
- **STATE:** DE
- **ZIP:** 19805
- **BUSINESS PHONE:** (302) 295-5783

**MAIL ADDRESS:**
- **STREET 1:** 974 CENTRE ROAD
- **STREET 2:** BUILDING 730
- **CITY:** WILMINGTON
- **STATE:** DE
- **ZIP:** 19805

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DowDuPont Inc.
- **DATE OF NAME CHANGE:** 20160211

?xml version='1.0' encoding='ASCII'? dd-20260521

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): May 26, 2026 (May 21, 2026)**

**DuPont de Nemours, Inc.** 

(Exact name of registrant as specified in its charter)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-38196** | **81-1224539** |
| (State or other jurisdiction of<br>incorporation) | (Commission file number) | (IRS Employer Identification No.) |

---

974 Centre Road, Building 730 Wilmington, Delaware 19805 <br> (Address of Principal Executive Offices) (Zip Code)

(302) 295-5783

(Registrant's Telephone Number, Including Area Code)

**<u>Not applicable</u>**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, par value $0.01 per share | DD | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

------

**Section 5 - Corporate Governance and Management**

Item 5.07 Submission of Matters to a Vote of Security Holders.

On May 21, 2026, DuPont de Nemours, Inc. (the "Company") held its Annual Meeting of Stockholders. As of the close of business on March 30, 2026, the record date for the Annual Meeting, (the "Record Date"), 409,867,418 shares of the Company's common stock, par value $0.01 per share, were outstanding and entitled to vote. A total of 341,319,707 shares of common stock were voted in person or by proxy, representing 83.27 percent of the shares entitled to be voted. The following are the final voting results on the matters considered and voted upon at the Annual Meeting, all of which are described in the Company's 2026 Proxy Statement.

<u>Agenda Item 1-Election of Directors.</u> The Company's stockholders elected the following 10 nominees to serve on the Board of Directors of the Company until the next annual meeting of stockholders or until their successors have been duly elected and qualified.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Director** | **For** | **Against** | **Abstain** | **Broker Non-Votes** |
| Amy G. Brady | 285052183 | 3175609 | 497739 | 52594176 |
| Edward D. Breen | 277484273 | 10738629 | 502629 | 52594176 |
| Ruby R. Chandy | 285967600 | 2066858 | 691073 | 52594176 |
| Alexander M. Cutler | 274539466 | 13320002 | 866063 | 52594176 |
| Eleuthère I. du Pont | 283578696 | 4649627 | 497208 | 52594176 |
| Lori D. Koch | 287059088 | 1157616 | 508827 | 52594176 |
| James A. Lico | 286791310 | 1391019 | 543202 | 52594176 |
| Frederick M. Lowery | 278519395 | 9665645 | 540491 | 52594176 |
| D.G. Macpherson | 285350824 | 2821535 | 553172 | 52594176 |
| Kurt B. McMaken | 284975799 | 3200207 | 549525 | 52594176 |

---

<u>Agenda Item 2-Advisory Resolution to Approve Executive Compensation.</u> The Company's stockholders approved, by advisory vote, the compensation of its named executive officers.

---

| | | | |
|:---|:---|:---|:---|
| **For** | **Against** | **Abstain** | **Broker Non-Votes** |
| 266,312,481 | 21,105,382 | 1,307,668 | 52,594,176 |

---

<u>Agenda Item 3-Ratification of the Appointment of the Independent Registered Public Accounting Firm.</u> The Company's stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2026.

---

| | | | |
|:---|:---|:---|:---|
| **For** | **Against** | **Abstain** | **Broker Non-Votes** |
| 338,791,200 | 1,984,333 | 544,174 |  |

---

<u>Agenda Item 4-Adoption and Approval of an Amendment to the Company's Certificate of Incorporation to Effect a Reverse Stock Split.</u> The Company's stockholders adopted and approved a proposed amendment to the Company's Certificate of Incorporation to effect a reverse stock split of the outstanding shares of the Company's common stock at a ratio of not less than 1-for-2 or more than 1-for-4 and a reduction in the number of authorized shares of the Company's common stock by a corresponding ratio.

---

| | | | |
|:---|:---|:---|:---|
| **For** | **Against** | **Abstain** | **Broker Non-Votes** |
| 335,519,752 | 4,389,749 | 1,410,206 |  |

---

------

**Section 7 - Regulation FD**

Item 7.01 Regulation FD Disclosure

On May 26, 2026, the Company issued a press release announcing, among other things, that the Board of Directors of the Company approved a ratio of 1-for-3 with respect to the previously announced reverse stock split (the "Reverse Stock Split"). The Company expects that the Reverse Stock Split will become effective on June 24, 2026, however the Board of Directors of the Company retains discretion to delay or abandon the Reverse Stock Split. The press release is attached as Exhibit 99.1 and is incorporated herein by reference.

The information contained in this Item 7.01, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of Section 18. Furthermore, the information contained in this report shall not be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended.

**Cautionary Statement Regarding Forward-Looking Statements**

This Current Report on Form 8-K contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect", "anticipate", "intend", "plan", "believe", "seek", "see", "will", "would", "target", "outlook", "stabilization", "confident", "preliminary", "initial" and similar expressions and variations or negatives of these words. All statements, other than statements of historical fact, are forward-looking statements, including statements regarding outlook, expectations and guidance, including with respect to the timing, completion, and benefits of the Reverse Stock Split.

Forward-looking statements address matters that are, to varying degrees, uncertain and subject to risks, uncertainties, and assumptions, many of which that are beyond DuPont's control, that could cause actual results to differ materially from those expressed in any forward-looking statements. Additional information concerning the risks, uncertainties and assumptions can be found in DuPont's filings with the SEC, including its Annual Report on Form 10-K for the year ended December 31, 2025, subsequent quarterly reports on Form 10-Q and other filings. Forward-looking statements are not guarantees of future results. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

**Section 9 - Financial Statements and Exhibits**

Item 9.01 Financial Statements and Exhibits.

(d)&nbsp;&nbsp;&nbsp;&nbsp;Exhibits.

---

| | |
|:---|:---|
| <u>[99.1](dupontrssannouncement.htm)</u> | Press release issued by DuPont de Nemours, Inc. on May 26, 2026, announcing the Board of Directors approval of the Reverse Stock Split. |
| 104 | The cover page from this Current Report on Form 8-K, formatted in Inline XBRL. |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
| | | **DUPONT DE NEMOURS, INC.** | **DUPONT DE NEMOURS, INC.** |
| | | Registrant | Registrant |
| Date: | May 26, 2026 | By: | /s/ Erik T. Hoover |
|  |  | Name: | Erik T. Hoover |
|  |  | Title: | Senior Vice President and General Counsel |

---

## Exhibit 99.1

**EXHIBIT 99.1**

![image.jpg](image.jpg)

NEWS RELEASE&nbsp;&nbsp;&nbsp;&nbsp;

**DuPont Announces Reverse Stock Split and Reaffirms 2026 Financial Guidance**

**WILMINGTON, Del., May 26, 2026 –** DuPont (NYSE: DD) today announced that its Board of Directors has approved a reverse stock split of the Company's common stock, par value $0.01 per share, at a ratio of 1-for-3 as well as a reduction in the number of authorized shares of its common stock by a corresponding ratio (the "Reverse Stock Split").

The Reverse Stock Split was approved by stockholders at the Company's 2026 Annual Meeting of Stockholders held on May 21, 2026, and is expected to become effective at 12:01 a.m. Eastern Time on June 24, 2026. DuPont's common stock is expected to begin trading on a split-adjusted basis on the New York Stock Exchange on June 24, 2026 under the existing ticker symbol "DD" with a new CUSIP number of 26614N 201.

At the effective time of the Reverse Stock Split, every three issued and outstanding shares of DuPont common stock will be automatically combined into one share of common stock. In addition, the total number of shares of the Company's common stock authorized for issuance will be reduced from 1,666,666,667 to 555,555,556. If the Reverse Stock Split were implemented as of May 22, 2026, the total number of outstanding shares would be reduced proportionately from approximately 405,058,202 to approximately 135,019,401, subject to adjustment for fractional shares.

No fractional shares will be issued in connection with the Reverse Stock Split. Stockholders who would otherwise be entitled to receive fractional shares will receive a cash payment from Computershare Trust Company, N.A., the Company's transfer agent, in lieu thereof. Proportionate adjustments will be made to the number of shares underlying the Company's outstanding equity awards, including stock options and restricted stock units, and to the exercise or conversion prices of such instruments. Similar adjustments will be made to outstanding warrants and other convertible securities.

The Reverse Stock Split will not affect any stockholder's proportionate ownership interest in the Company, except for adjustments resulting from the treatment of fractional shares.

Stockholders holding shares in book-entry form or through a bank, broker, or other nominee will have their holdings automatically adjusted to reflect the Reverse Stock Split. Stockholders holding physical certificates will receive instructions from the Company's transfer agent regarding exchange procedures.

The Company today also reaffirmed its second quarter and full year 2026 financial guidance for net sales, operating EBITDA and adjusted EPS, and intends to present its per share metrics, including earnings per share, on a split-adjusted basis when reported. Below represents our adjusted earnings per share guidance, giving effect to the Reverse Stock Split which results in a weighted average diluted share count for the second quarter and full year 2026 of approximately 137 million shares:

---

| | | |
|:---|:---|:---|
|  | &nbsp;&nbsp;**2Q'26E** | &nbsp;&nbsp;**Full Year 2026E** |
| Adjusted EPS<sup>(1)</sup> – Prior Guidance | &nbsp;&nbsp;~$0.59 | &nbsp;&nbsp;$2.35 - $2.40 |
| Adjusted EPS<sup>(1)</sup> – Effect of Reverse Stock Split | &nbsp;&nbsp;~$1.75 | &nbsp;&nbsp;$7.02 - $7.16 |

---

(1)Adjusted Earnings Per Share is a non-GAAP measures and only reflects continuing operations. The Company has not provided forward-looking U.S. GAAP financial measures or a reconciliation of forward-looking non-GAAP financial measures to the most comparable U.S. GAAP financial measures on a forward-looking basis because the Company is unable to do so without unreasonable effort or expense, including due to the fact that the Company is unable to predict with reasonable certainty the ultimate outcome of certain future events. These events include, among others, the impact of portfolio changes, including asset sales, mergers, acquisitions, and divestitures; contingent liabilities related to litigation, environmental and indemnifications matters; impairments and discrete tax items. These items are uncertain, depend on various factors, and could have a material impact on U.S. GAAP results for the guidance period. The most directly comparable U.S. GAAP financial measure to Adjusted Earnings Per Share is Earnings Per Share.

------

**About DuPont**

DuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

DuPont<sup>TM</sup> and all products, unless otherwise noted, denoted with <sup>TM</sup>, <sup>SM</sup> or® are trademarks, service marks or registered trademarks of affiliates of DuPont de Nemours, Inc.

---

| | |
|:---|:---|
| **For further information contact:**<br>**DuPont**<br>**Investors:**<br>Ann Giancristoforo<br>ann.giancristoforo@dupont.com<br>+1 989-294-5890 | <br>**Media:**<br>Dan Turner<br>daniel.a.turner@dupont.com<br>+1 302-299-7628 |

---

**Cautionary Statement Regarding Forward-Looking Statements** 

This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target, "outlook," "stabilization," "confident," "preliminary," "initial," and similar expressions and variations or negatives of these words. All statements, other than statements of historical fact, are forward-looking statements, including statements regarding outlook, expectations and guidance. Forward-looking statements address matters that are, to varying degrees, uncertain and subject to risks, uncertainties, and assumptions, many of which that are beyond DuPont's control, that could cause actual results to differ materially from those expressed in any forward-looking statements.

Forward-looking statements are not guarantees of future results. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

<br>